Effect of cardiac resynchronization therapy on endothelium-dependent vasodilatation in the cutaneous microvasculature

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 4, 2012, Pages 377-384

  Tesselaar, Erik ^a,b   Schiffer, Angélique ^a   Widdershoven, Jos ^a   Broers, Herman ^a   Hendriks, Eric ^a   Luijten, Kees ^a   Creusen, John ^a  

^a CPRLab   (Netherlands)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

biventricular pacing; endothelium; heart failure; microcirculation

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEATING; HUMAN; IONTOPHORESIS; MALE; MICROVASCULATURE; MUSCLE FUNCTION; OUTCOME ASSESSMENT; PERFUSION; SMOOTH MUSCLE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ACETYLCHOLINE; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOTONIC AGENTS; FEMALE; HEART FAILURE; HEATING; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; SKIN; TREATMENT OUTCOME; VASODILATION;

EID: 84859569424     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03313.x     Document Type: Article

References (29)

1. Andersson SE, Edvinsson ML, Edvinsson L,. Cutaneous vascular reactivity is reduced in aging and in heart failure: Association with inflammation. Clin Sci (Lond) 2003; 105: 699-707.
2. Drexler H, Hornig B,. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31: 51-60.
3. Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H,. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 2005; 26: 65-69.
4. Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V, Meinertz T,. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 2005; 25: 1174-1179.
5. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T,. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
6. Andreassen AK, Gullestad L, Holm T, Simonsen S, Kvernebo K,. Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients. Clin Transplant 1998; 12: 324-332.
7. Hognestad A, Holm T, Simonsen S, Kjekshus J, Andreassen AK,. Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation. J Card Fail 2005; 11: 447-454.
8. Roig E, Cuppoletti A, Masotti M, Kianco R, Vallejos I, Sitges M, Ortiz J, et al,. Assessment of peripheral endothelial-dependent vasodilatation within the first year after heart transplantation. J Heart Lung Transplant 2009; 28: 299-304.
9. Cleland JG, Calvert MJ, Verboven Y, Freemantle N,. Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study. Am Heart J 2009; 157: 457-466.
10. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
11. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JG,. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction-A systematic review and meta-analysis. Eur J Heart Fail 2006; 8: 433-440.
12. Akar JG, Al-Chekakie MO, Fugate T, Moran L, Froloshki B, Varma N, Santucci P, et al,. Endothelial dysfunction in heart failure identifies responders to cardiac resynchronization therapy. Heart Rhythm 2008; 5: 1229-1235.
13. Erol-Yilmaz A, Atasever B, Mathura K, Lindeboom J, Wilde A, Ince C, Tukkie R,. Cardiac resynchronization improves microcirculation. J Card Fail 2007; 13: 95-99.
14. Krum H,. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: Full text (update 2005). Eur Heart J 2005; 26: 2472; author reply 2473-2474.
15. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, et al,. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al,. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
17. Henricson J, Tesselaar E, Persson K, Nilsson G, Sjoberg F,. Assessment of microvascular function by study of the dose-response effects of iontophoretically applied drugs (acetylcholine and sodium nitroprusside)-Methods and comparison with in vitro studies. Microvasc Res 2007; 73: 143-149.
18. Tesselaar E, Sjoberg F,. Transdermal iontophoresis as an in-vivo technique for studying microvascular physiology. Microvasc Res 2011; 81: 88-96.
19. Droog EJ, Henricson J, Nilsson GE, Sjoberg F,. A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 2004; 67: 197-202.
20. Bauersachs J, Schafer A,. Endothelial dysfunction in heart failure: Mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2004; 2: 115-124.
21. Flevari P, Theodorakis G, Paraskevaidis I, Kolokathis F, Kostopoulou A, Leftheriotis D, Kroupis C, et al,. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement. Europace 2006; 8: 44-50.
22. Andersson SE, Edvinsson ML, Alving K, Edvinsson L,. Vasodilator effect of endothelin in cutaneous microcirculation of heart failure patients. Basic Clin Pharmacol Toxicol 2005; 97: 80-85.
23. RG IJ, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarre-van de Waal HA, Serne EH, Stehouwer CD,. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003; 33: 536-542.
24. Morris SJ, Shore AC, Tooke JE,. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995; 38: 1337-1344.
25. Cupisti A, Rossi M, Placidi S, Fabbri A, Morelli E, Vagheggini G, Meola M, et al,. Responses of the skin microcirculation to acetylcholine in patients with essential hypertension and in normotensive patients with chronic renal failure. Nephron 2000; 85: 114-119.
26. Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C,. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 2004; 173: 97-102.
27. Kellogg DL Jr., In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 2006; 100: 1709-1718.
28. Kellogg DL Jr., Zhao JL, Wu Y,. Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans. J Appl Physiol 2009; 107: 1438-1444.
29. Kellogg DL, Jr., Zhao JL, Coey U, Green JV,. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 2005; 98: 629-632.